ZVRA · Zevra Therapeutics, Inc. · Documents
$10.25
-0.08 (-0.77%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$614.03M
Shares
59.38M
Volume · Oct 22
537.3K
Avg daily vol (3M)
1.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-02-09 | — | |
| 8-K | — | 2021-01-27 | — | |
| 8-K | — | 2021-01-26 | — | |
| S-3 | — | 2021-01-13 | — | |
| 8-K | — | 2021-01-13 | 2021-01-08 | |
| 8-K | — | 2021-01-05 | — | |
| S-1/A | — | 2021-01-05 | — | |
| 8-K | — | 2020-12-28 | 2020-12-23 | |
| 8-K | — | 2020-12-28 | 2020-12-23 | |
| S-1/A | — | 2020-12-28 | — | |
| 8-K | — | 2020-12-21 | 2020-12-20 | |
| S-1/A | — | 2020-12-21 | — | |
| S-1 | — | 2020-11-25 | — | |
| 8-K/A | — | 2020-11-24 | 2020-11-23 | |
| 8-K | — | 2020-11-23 | — | |
| DEFA14A | — | 2020-11-23 | — | |
| 8-K | — | 2020-11-19 | 2020-11-18 | |
| 8-K/A | — | 2020-10-30 | 2020-10-29 | |
| 10-Q | — | 2020-10-30 | 2020-09-30 | |
| DEFA14A | — | 2020-10-29 | — | |
| 8-K | — | 2020-10-29 | — | |
| 8-K | — | 2020-10-26 | — | |
| DEFA14A | — | 2020-10-26 | — | |
| DEF 14A | — | 2020-10-08 | 2020-10-27 | |
| DEFA14A | — | 2020-09-25 | — | |
| 8-K | — | 2020-09-25 | — | |
| PRE 14A | — | 2020-09-25 | — | |
| 8-K | — | 2020-08-12 | — | |
| 10-Q | — | 2020-08-12 | 2020-06-30 | |
| 8-K | — | 2020-07-17 | — | |
| 8-K | — | 2020-06-24 | — | |
| 8-K/A | — | 2020-06-19 | 2020-06-18 | |
| 8-K | — | 2020-06-19 | — | |
| 8-K | — | 2020-06-18 | — | |
| 8-K | — | 2020-05-20 | — | |
| 10-Q | — | 2020-05-13 | 2020-03-31 | |
| 8-K | — | 2020-05-12 | — | |
| DEF 14A | — | 2020-05-08 | 2020-06-19 | |
| DEFA14A | — | 2020-05-08 | — | |
| 8-K | — | 2020-05-04 | — | |
| 8-K | — | 2020-04-13 | — | |
| 10-K/A | — | 2020-04-08 | 2019-12-31 | |
| 8-K | — | 2020-04-02 | — | |
| S-3/A | — | 2020-04-01 | — | |
| 8-K | — | 2020-03-02 | — | |
| 8-K | — | 2020-02-28 | — | |
| 10-K | — | 2020-02-28 | 2019-12-31 | |
| 8-K | — | 2020-02-18 | 2020-02-17 | |
| 8-K | — | 2020-02-10 | — | |
| 8-K | — | 2020-01-16 | 2020-01-15 |
Showing 151–200 of 202 filings
Key facts
CIK
1434647
CUSIP
488445206
13F (30d)
22 filings
22 filers
Visit website
Investor relations